Newamsterdam Pharma Stock Price Prediction
| NAMS Stock | 31.88 0.75 2.30% |
Momentum 36
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.38) | EPS Estimate Current Year (1.33) | EPS Estimate Next Year (1.50) | Wall Street Target Price 49.6325 | EPS Estimate Current Quarter (0.35) |
Using NewAmsterdam Pharma hype-based prediction, you can estimate the value of NewAmsterdam Pharma from the perspective of NewAmsterdam Pharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards NewAmsterdam Pharma using NewAmsterdam Pharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards NewAmsterdam using crowd psychology based on the activity and movement of NewAmsterdam Pharma's stock price.
NewAmsterdam Pharma Short Interest
An investor who is long NewAmsterdam Pharma may also wish to track short interest. As short interest increases, investors should be becoming more worried about NewAmsterdam Pharma and may potentially protect profits, hedge NewAmsterdam Pharma with its derivative instruments, or be ready for some potential downside.
200 Day MA 27.2226 | Short Percent 0.0664 | Short Ratio 7.53 | Shares Short Prior Month 6.2 M | 50 Day MA 35.634 |
NewAmsterdam Pharma Hype to Price Pattern
Investor biases related to NewAmsterdam Pharma's public news can be used to forecast risks associated with an investment in NewAmsterdam. The trend in average sentiment can be used to explain how an investor holding NewAmsterdam can time the market purely based on public headlines and social activities around NewAmsterdam Pharma. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of NewAmsterdam Pharma's market sentiment to its price can help taders to make decisions based on the overall investors consensus about NewAmsterdam Pharma.
NewAmsterdam Pharma Implied Volatility | 0.95 |
NewAmsterdam Pharma's implied volatility exposes the market's sentiment of NewAmsterdam Pharma stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if NewAmsterdam Pharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that NewAmsterdam Pharma stock will not fluctuate a lot when NewAmsterdam Pharma's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in NewAmsterdam Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying NewAmsterdam because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
NewAmsterdam Pharma after-hype prediction price | USD 31.89 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current NewAmsterdam contract
Based on the Rule 16, the options market is currently suggesting that NewAmsterdam Pharma will have an average daily up or down price movement of about 0.0594% per day over the life of the 2026-03-20 option contract. With NewAmsterdam Pharma trading at USD 31.88, that is roughly USD 0.0189 . If you think that the market is fully incorporating NewAmsterdam Pharma's daily price movement you should consider acquiring NewAmsterdam Pharma options at the current volatility level of 0.95%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
NewAmsterdam | Build AI portfolio with NewAmsterdam Stock |
NewAmsterdam Pharma After-Hype Price Density Analysis
As far as predicting the price of NewAmsterdam Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in NewAmsterdam Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of NewAmsterdam Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
NewAmsterdam Pharma Estimiated After-Hype Price Volatility
In the context of predicting NewAmsterdam Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on NewAmsterdam Pharma's historical news coverage. NewAmsterdam Pharma's after-hype downside and upside margins for the prediction period are 28.96 and 34.82, respectively. We have considered NewAmsterdam Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
NewAmsterdam Pharma is very steady at this time. Analysis and calculation of next after-hype price of NewAmsterdam Pharma is based on 3 months time horizon.
NewAmsterdam Pharma Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as NewAmsterdam Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading NewAmsterdam Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with NewAmsterdam Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.24 | 2.93 | 0.01 | 0.09 | 10 Events / Month | 8 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
31.88 | 31.89 | 0.03 |
|
NewAmsterdam Pharma Hype Timeline
NewAmsterdam Pharma is now traded for 31.88. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of -0.09. NewAmsterdam is expected to increase in value after the next headline, with the price projected to jump to 31.89 or above. The average volatility of media hype impact on the company the price is over 100%. The price appreciation on the next news is projected to be 0.03%, whereas the daily expected return is now at -0.24%. The volatility of related hype on NewAmsterdam Pharma is about 741.77%, with the expected price after the next announcement by competition of 31.79. The company reported the previous year's revenue of 45.56 M. Net Loss for the year was (241.6 M) with profit before overhead, payroll, taxes, and interest of 35.24 M. Given the investment horizon of 90 days the next expected press release will be in about 10 days. Check out NewAmsterdam Pharma Basic Forecasting Models to cross-verify your projections.NewAmsterdam Pharma Related Hype Analysis
Having access to credible news sources related to NewAmsterdam Pharma's direct competition is more important than ever and may enhance your ability to predict NewAmsterdam Pharma's future price movements. Getting to know how NewAmsterdam Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how NewAmsterdam Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| KYMR | Kymera Therapeutics | (4.59) | 11 per month | 2.65 | 0.07 | 4.40 | (4.46) | 49.42 | |
| VKTX | Viking Therapeutics | (2.48) | 10 per month | 0.00 | (0.05) | 7.49 | (5.49) | 19.06 | |
| IMVT | Immunovant | (0.64) | 11 per month | 2.14 | 0.14 | 5.31 | (3.63) | 20.44 | |
| AKRO | Akero Therapeutics | (0.83) | 4 per month | 0.63 | 0.10 | 3.29 | (2.12) | 16.73 | |
| CRNX | Crinetics Pharmaceuticals | (0.06) | 11 per month | 2.29 | 0.11 | 4.38 | (4.63) | 19.30 | |
| ACLX | Arcellx | (1.05) | 9 per month | 0.00 | (0.1) | 4.75 | (4.57) | 22.18 | |
| PRAX | Praxis Precision Medicines | 9.16 | 10 per month | 3.91 | 0.15 | 9.33 | (6.06) | 36.21 | |
| LGND | Ligand Pharmaceuticals Incorporated | (2.38) | 10 per month | 2.06 | (0) | 3.51 | (2.76) | 18.09 | |
| SLNO | Soleno Therapeutics | (0.25) | 8 per month | 0.00 | (0.13) | 5.19 | (4.39) | 31.78 | |
| CGON | CG Oncology Common | (0.83) | 8 per month | 2.59 | 0.09 | 5.15 | (4.40) | 33.66 |
NewAmsterdam Pharma Additional Predictive Modules
Most predictive techniques to examine NewAmsterdam price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for NewAmsterdam using various technical indicators. When you analyze NewAmsterdam charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About NewAmsterdam Pharma Predictive Indicators
The successful prediction of NewAmsterdam Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as NewAmsterdam Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of NewAmsterdam Pharma based on analysis of NewAmsterdam Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to NewAmsterdam Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to NewAmsterdam Pharma's related companies. | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 170.67 | 153.6 | 87.76 | PTB Ratio | 3.2 | 2.88 | 1.82 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NewAmsterdam Stock Analysis
When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.